GlassScriptPhysician profile
Allen Greenberg
NPI 1720097207
$29,374.94
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,225 · 2020: $4,825 · 2021: $19K.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $12,190.00 | 2020-2021 | |
| Incyte Corporation | $4,539.77 | 2020-2021 | |
| Jazz Pharmaceuticals INC. | $3,885.00 | 2021 | |
| Cardinal Health 105 LLC | $2,875.65 | 2019 | |
| Karyopharm Therapeutics INC. | $2,325.00 | 2020 | |
| Kite Pharma, INC. | $1,774.43 | 2019 | |
| Astellas Pharma US INC | $500.00 | 2021 | |
| Genzyme Corporation | $500.00 | 2019-2021 | |
| Celgene Corporation | $231.23 | 2019 | |
| Glaxosmithkline, LLC. | $135.00 | 2021 | |
| Janssen Biotech, INC. | $121.87 | 2019 | |
| Novartis Pharmaceuticals Corporation | $102.57 | 2019 | |
| Cardinal Health 110 LLC | $100.00 | 2020 | |
| Verastem, INC. | $94.42 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allen Greenberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.